European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-05-27

Nanocatalytic drugs towards Alzheimer's disease

Cel

Here is proposed nano-scale synthesis and combinatorial screening of medium sized peptide-transition metal catalyst libraries with the aim of producing libraries for screening highly selective catalysts for development of nano-medicines. The implementation of catalytic molecules as medicines is a new paradigm in treatment that can overcome a number of the difficulties with present drugs. As with real enzymes the enzyme capacity of these catalysts comes from productive and selective binding of the TS of reaction. The aim is to develop enzyme like molecules: Organozymes, characterized by high turnover as well as both high chemo- and high regio-selectivity. Novel ligands for transition metals containing functional groups will be synthesized and incorporated into encoded solid phase combinatorial libraries on bio-compatible resins. Encoding ensures extremely fast and simple structure/activity assessment. The screening of split-mix combinatorial libraries of organozymes will have the distinct purpose of developing of artificial proteases as drugs. This involves e. g. Fe, Zn and Cu peptide complexes and combinatorial FRET-substrate screening for proteolytic activity to identify artificial organozyme proteases that act as nano-medicine towards marker proteins in Alzheimers disease. Nano-container delivery of catalytic drugs to target tissue will be developed.

Zaproszenie do składania wniosków

FP7-PEOPLE-2013-IEF
Zobacz inne projekty w ramach tego zaproszenia

Koordynator

KOBENHAVNS UNIVERSITET
Wkład UE
€ 230 809,80
Adres
NORREGADE 10
1165 Kobenhavn
Dania

Zobacz na mapie

Region
Danmark Hovedstaden Byen København
Rodzaj działalności
Higher or Secondary Education Establishments
Kontakt administracyjny
Bjarne Friis Ploumark (Mr.)
Linki
Koszt całkowity
Brak danych